| FDA                   Home Page | Search FDA Site |                   FDA A-Z Index | Contact                   FDAFDA Consumer--Past Issues
2004 | 2003 | 2002                   | 2001 | 20001999 | 1998 | 1997                   | 1996 | 1995 | 1994                   | 1993 | 1992                   | 1991 | 1990                   | 1989
2004 (Vol. 38)- January-February (No. 1)   Features:  Hispanic Americans,  Listeria,  ultrasound                     'keepsake' images, advisory committees, counterterrorism,                     obesity, healthy pets, cervical cancer screening
- March-April (No. 2)    Features:  ephedra, OTC pain relief products, the                     flu, joint replacement, GRAS foods, chronic pain, food safety,                     cosmetic treatments, illegal drugs and dietary supplements
- May-June (No. 3)    Features:  prescription drugs, mercury in fish, FDA                     science, counterfeit drugs, obesity, colorectal cancer, summer                     safety, androstenedione, acrylamide, Mad Cow disease
- July-August (No. 4)    Features:  generic drugs, dietary supplements, drug                     interactions, diabetes, truth in advertising, homemade ice                     cream, pet care, drug maker fined
- September-October (No. 5)     Features:  medical use for leeches, psoriasis, online                     drugs, cancer vaccines, speeding approval of medical products,                     "raw milk," breast implants
2003 (Vol. 37)- January-February (No. 1)   Features:  Commissioner McClellan, acrylamide in food,                     pediatric drugs, contact lenses, West Nile virus, depression,                     MSG, pain relievers
- March-April (No. 2)   Features:  direct-to-consumer advertising, estrogen                     and postmenopausal women, Commissioner McClellan, medical                     device user fees, asthma, smallpox, FDA scientists, prescription                     drug abuse
- May-June (No. 3)   Features:  ephedra, new medical technologies, breast-feeding,                     Liberty Shield, medication safety, cloning, healthy traveling,                     clinical trials
- July-August (No. 4)   Features:  cancer, problems with cosmetics and dietary                     supplements, SARS, Alzheimer's, Hispanic health, blood safety,                     medical device injuries
- September-October (No. 5)   Features:  food security, MedWatch, generic drugs,                      trans  fats, nasal flu vaccine, press officer Emil Corwin,                     clinical trials, aspirin
- November-December (No. 6)   Features:  FDA's bionic skeleton, orphan products,                     tanning, heart disease, the climbing wheelchair, genetically                     engineered food, cochlear implants, menopausal hormone therapy
2002 (Vol. 36)- January-February (No. 1)   Features:  accutane, food safety and teens, patient representatives,                     pulling drugs from the market, weight loss, diabetes
- March-April (No. 2)   Features:  obesity, genital herpes, dietary supplements, blindness,                     leukemia, devices for congenital heart defects
- May-June (No. 3)   Features:  diabetes, robot-assisted surgery, gum disease, wound                     healing, allergies, Mad Cow disease 
- July-August (No. 4)   Features:  biologics regulation, Botox Cosmetic, bottled water,                     drug review, electric muscle stimulators, sunglasses, antibiotic                     resistance, OTC drug label, dietary supplements in pet food
- September-October (No. 5)   Features:  blood pressure monitors, vaccine shortages, osteoporosis                     and men, imported drugs, generic drugs, food freshness, minor                     species
- November-December (No. 6)   Features:  oxygen bars, the "Poison Squad," sleep,                     medicine use, sunlight and cosmetics, microwaving plastics,                     public affairs specialists
2001 (Vol. 35)- January-February (No. 1)   Features:  antibiotic resistance, flu shots, hair care, PPA,                     genetic modification
- March-April (No. 2)   Features:  product approvals, bioengineered food, "Mad                     Cow" disease, food safety, accutane, Frances Kelsey,                     drugs and quality of life
- May-June (No. 3)   Features:  GlucoWatch, drug-induced liver injury, medical devices                     for home use, drugs and pregnancy, shingles, pet food
- July-August (No. 4)   Features:  treating leukemia with Gleevec, fleas and ticks,                     food allergies, growing bones, vaccine safety, hepatitis C,                     irritable bowel syndrome
- September-October (No. 5)   Features:  Internet health fraud, type 2 diabetes, human research,                     food safety, prescription drug abuse, vision correction, FDA                     student interns
- November-December (No. 6)   Features:  women and diabetes, 9- 11 terrorist attacks, full-body                     CT scans, colds and flu, home diagnostic tests, hysterectomy                     alternatives, AIDS 
2000 (Vol. 34)- January-February (No. 1)   Features:  experimental drugs, placebos, bioengineered foods,                     online drugs, JIFSAN
- March-April (No. 2)   Features:  medical milestones, GHB, tampons, the medicine cabinet,                     FDA science
- May-June (No. 3)   Features:  telemedicine, soy, post-traumatic stress disorder,                     arthritis, cosmetic laser surgery
- July-August (No. 4)   Features:  saline breast implants, medical gases, pharmacy                     compounding, sunscreens, bone marrow transplants, juvenile                     diabetes
- September-October (No. 5)   Features:  medical errors, reusing medical devices, dietary                     guidelines, gene therapy
- November-December (No. 6)   Features:  treating animals, mifepristone, food safety, heart-healthy                     foods, robotic surgery, colon cancer, liposuction, cell phones                   
1999 (Vol. 33)- January-February (No. 1)   Features:  X-rays, mammography, sprouts, cholesterol, epilepsy
- March-April (No. 2)   Features:  emphysema, heart disease, pregnancy, hepatitis C,                     food fraud
- May-June (No. 3)   Features:  lung cancer, Lyme disease, dentistry, children's                     drugs, orphan drugs 
- July-August (No. 4)   Features:  breast cancer, AIDS, hypertension,  Chlamydia,                      drug labels
- September-October (No. 5)   Features:  product safety,  Campylobacter,  ventilators,                     Crohn's disease, food safety surveys
- November-December (No. 6)    Features:  Y2K, sugar substitutes, menopause, health fraud,                     social phobias
1998 (Vol. 32)- January-February (No. 1)   Features:  TV drug ads, kidney dialysis, lead, milk labels,                     in-flight medical emergencies, drugs from the sea
- March-April (No. 2)   Features:  allergies, stroke, contact lenses, condoms, back                     pain, AHAs
- May-June (No. 3)   Features:  cosmetics, irradiation, migraines, Alzheimer's,                     mononucleosis
- July-August (No. 4)   Features:  insomnia, Parkinson's disease, wild animals, depression,                     laser eye surgery
- September-October (No. 5)   Features:  egg safety, juice safety, home cooking, thermometers,                     prostate cancer, dietary supplements 
- November-December (No. 6)   Features:  MedWatch, health claims on labels, antibiotics,                     surgery
1997 (Vol. 31)- January-February (No. 1)   Features:  AIDS, artificial skin, infertility, breast reduction,                     tropical disease 
- March (No. 2)   Features:  prosthetics, phobias, 5-a-day, debarment, menopause
- April (No. 3)   Features:  hair replacement, arrhythmia, chronotherapy, contraceptives,                     CFSAN 
- May-June (No. 4)   Features:  OTC drug labels, CFCs, telemedicine, nutrition,                     brain tumors, diabetes
- July-August (No. 5)   Features:  dieter's teas, heat, drug labels, fiber, incontinence,                     attention disorder 
- September-October (No. 6)   Features:  food safety, thalidomide, older adults, drug regulation,                     schizophrenia, osteoporosis 
- November-December (No. 7)   Features:  safe food, seafood, prescription drug shortages,                     handling reptiles safely, salt and blood pressure, quitting                     smoking
1996 (Vol. 30)- January-February (No. 1)   Features:  children's medicine, aphrodisiacs, weight loss,                     smoking, testicular cancer 
- March (No. 2)   Features:  nutrition and the elderly, childhood poisoning,                     arthritis, tea, federal-state programs
- April (No. 3)   Features:  FDA rulemaking process, healthy snacks, broken bones,                     infectious diseases, yeast infections
- May (No. 4)   Features:  allergies, OTC antimicrobials, sickle cell anemia,                     alcoholism, chemical photosensitivity
- June (No. 5)   Features:  safe sunning, xenotransplants, infant formula, manic                     depression, online health information
- July-August (No. 6)   Features:  fat substitutes, tetanus, dehydration, fleas and                     ticks, CDER
- September (No. 7)   Features:  folate/birth defects, ALS, osteoporosis, hair care,                     poison ivy
- October (No. 8)   Features:  tobacco regulation, Pap tests, colds and flu, Paget's                     disease, women's health, pancreatic diseases
- November (No. 9)    Features:  OTC drugs, birth defects, asthma, rabies, medical                     devices
- December (No. 10)    Features:  devices, sulfites, homeopathy, non-Hodgkin's lymphoma
1995 (Vol. 29)-  January-February                     1995 (No. 1)  *   Features:  HACCP, OTC painkillers, dental lasers,                     new food label
-  March 1995                     (No. 2)  *   Features:  drug trials, braces, children's foods,                     gout, advisory committees
- *April 1995                     (No. 3)  *   Features:  genetic engineering, [psoriasis, HIV, blood,                     estrogen]
- May 1995 (No.                     4)   Features:  [acne, devices, genital warts, testosterone]
- June 1995 (No.                     5)   Features:  [food label, medicine, UTIs, upset stomach,                     lung cancer]                     July-August (No. 6)   Features:  forensics, skin cancer, eye surgery, men's                     health, prescriptions 
- September (No. 7)   Features:  chickenpox vaccine, antibiotic-resistant                     infections, food labels, medical diagnostic software, legitimate                     uses for psychedelic drugs
- October (No. 8)   Features:  drug review, vegetarian diets, food safety,                     breastfeeding, recalls
- November (No. 9)   Features:  patient education, breast implants, glaucoma,                     snakebite, interstitial cystitis 
- December (No. 10)    Features:  vaccines, AIDS, botulinum toxin, fingernails                     * The 1995 issues marked with an asterisk are available only                     in text format.
**1989 - 1994 Issues
Not all the articles in these older issues are available online.                   Those that are are only in text format.

**Search FDA Consumer:**Powered by Google

FDA Consumer Home Page

Subscription Information

**Past Issues**

**Special Issues:**
-  Drug                       Development 
-  Food                       Labeling 

Contact the Editorial Staff

Consumer Publications                     Catalog

FDA Manuals and Publications

*FDA Consumer* is the official magazine                   of the U.S. Food and Drug Administration.

Text in the articles in *FDA Consumer* may                   be republished without permission. Credit to *FDA Consumer*                   as the source is appreciated. |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| FDA Home Page | Search           FDA Site | FDA A-Z Index | Contact           FDA | Privacy | Accessibility

FDA Consumer Magazine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |